2004
DOI: 10.1016/j.jhin.2004.01.003
|View full text |Cite
|
Sign up to set email alerts
|

The impact of pan-resistant bacterial pathogens on survival after lung transplantation in cystic fibrosis: results from a single large referral centre

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
58
1
4

Year Published

2008
2008
2024
2024

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 96 publications
(67 citation statements)
references
References 20 publications
2
58
1
4
Order By: Relevance
“…Two studies did not observe worse outcomes in this setting (18,153), but a third study did. Hadjiliadis and colleagues found that 43.7% of 103 CF patients undergoing lung transplantation were infected with panresistant bacteria other than Burkholderia (235).…”
Section: Pseudomonas Aeruginosamentioning
confidence: 87%
“…Two studies did not observe worse outcomes in this setting (18,153), but a third study did. Hadjiliadis and colleagues found that 43.7% of 103 CF patients undergoing lung transplantation were infected with panresistant bacteria other than Burkholderia (235).…”
Section: Pseudomonas Aeruginosamentioning
confidence: 87%
“…There are only a few studies that examine the success rate of Pseudomonas eradication in post-transplant recipients [3,5,17,19]. In a larger study, including 87 patients with pre-transplant sinus surgery, 82 and 87% had persistent PNC and PPC, respectively [17].…”
Section: Discussionmentioning
confidence: 99%
“…Renal transplant patients are more likely to develop renal toxicity by different mechanisms (10), and renal dysfunction is adversely related to organ and recipient survival (11). On the other hand, due to the severity of the patients' conditions and the frequent use of antimicrobials, Gram-negative bacterial multiresistance is a major issue in hematopoietic stem cell transplantation and in solid organ transplantation (12)(13)(14), showing the ever-increasing need for polymyxin employment in this setting. Very few data regarding polymyxin toxicity, especially nephrotoxicity, are available for transplant patients.…”
mentioning
confidence: 99%